My site

DUBLIN - Monday, November 12th 2012 [ME NewsWire]

    Fourth-quarter and fiscal 2012 results negatively impacted by extra selling week in 2011 and unfavorable foreign exchange rate movement
    Fourth-quarter net sales down 3% (flat excluding foreign exchange rate movement); Medical Devices sales down 1% (up 2% excluding foreign exchange rate movement)
    Fourth-quarter diluted GAAP earnings per share from continuing operations were $0.96; excluding specified items, adjusted diluted earnings per share from continuing operations were $1.02
    Fiscal 2012 diluted GAAP earnings per share from continuing operations were $3.92; excluding specified items, adjusted diluted earnings per share from continuing operations were $4.26, up 7%

(BUSINESS WIRE)-- Covidien plc (NYSE: COV) today reported results for the fourth quarter of fiscal 2012 (July - September 2012). Fourth-quarter net sales of $3.00 billion were ... Read more »

NEW YORK - Sunday, November 11th 2012 [ME NewsWire]

    Third Quarter Results
        Revenue from Continuing Operations of $222 million
        GAAP EPS from Continuing Operations of $0.35, includes $0.28 non-recurring tax benefit
        Non-GAAP EPS from Continuing Operations of $0.09
    Announces Corporate Restructuring
        Concentrates resources on core business in North America and key European & Asian markets supported by increased marketing and sales
        Pursues sale of ChinaHR and evaluates options in developing markets
        Combined actions expected to reduce Operating Expense by approximately $130 million on an annualized basis
    Review of Strategic Alternatives Ongoing

... Read more »

BOUDRY, Switzerland - Sunday, November 11th 2012 [ME NewsWire]

(BUSINESS WIRE)-- Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today announced that its phase III study of ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in combination with gemcitabine in treatment-naïve patients with advanced pancreatic cancer met its primary endpoint of overall survival. In the study, ABRAXANE in combination with gemcitabine demonstrated a statistically significant improvement in overall survival compared to patients receiving gemcitabine alone.

In the MPACT (Metastatic Pancreatic Adenocarcinoma Clinical Trial) study, a Celgene-sponsored, open-label, randomized, international study 861 metastatic pancreatic cancer patients were randomized to receive either ABRAXANE plus gemcitabine (125 mg/m2 followed by 1000 mg/m2 gemcitabine for 3 weeks followed by a week of rest) or gemcitabine alone (1000 mg/m2 administered ... Read more »

ME Newswire / Business Wire

INGELHEIM, Germany - Sunday, November 11th 2012

Pivotal Phase III interferon-free study being initiated following positive Phase IIb results

For media outside of the U.S.A. , UK and Canada only

Final results from the Phase IIb study, SOUND-C2, confirmed that up to 85 percent of hepatitis C (HCV) patients infected with the most prevalent type of HCV globally, genotype-1b (GT-1b), achieved and subsequently sustained viral cure with Boehringer Ingelheim’s interferon-free regimen, when measured 12 and 24 weeks (SVR12 & SVR24) after treatment. This high cure rate was achieved following just 28 weeks of treatment with the highly effective polymodal* therapy, faldaprevir (BI 201335)+, a potent next wave once daily protease inhibitor, and BI 207127+, a potent non-nucleoside polymerase inhibitor, plus ribavirin.1

These full results from the largest interferon-free trial of its kind to be concluded to date, include patients with ... Read more »

HONG KONG - Saturday, November 10th 2012 [ME NewsWire]

    Record pre-tax income of US$204 million
    Record quarterly sales of US$8.7 billion
    Record market share of 15.6 percent
    Basic EPS of 1.58 US cents, or 12.25 HK cents
    Net cash reserves of US$3.6 billion (as of September 30, 2012)

(BUSINESS WIRE)-- Lenovo Group today reported results for its second fiscal quarter ended September 30, 2012. Outgrowing the market in all geographies, Lenovo continued its push towards becoming the number one vendor in the PC industry, with record quarterly sales of $8.7 billion, an 11 percent increase year-over-year. While growing faster than the top four PC companies for three straight years, Lenovo also turned in another quarter of record pre-tax income at US$204 million, evidence that the Company continues to build upon its track record of profitable growth.

During the second fis ... Read more »

SAN ANTONIO - Friday, November 9th 2012 [ME NewsWire]

(BUSINESS WIRE)-- Today, Kinetic Concepts, Inc. (KCI) announced that it has closed the sale of its Therapeutic Support Systems™ (TSS) business to Getinge AB (sto: GETIB) for a total deal value of $275 million.

The TSS business, now owned by Getinge, includes a comprehensive portfolio of specialty therapeutic beds, mattress replacement systems, support surfaces and patient mobility devices for the therapeutic wound care, bariatric and critical care settings. To ensure that TSS customers continue to receive best-in-class service and commitment following the closing, KCI will continue to provide certain transition services to Getinge for a period of time.

"Changing the clinical practice of medicine, a core competency that originated with the founding of the TSS business, is and will continue to be, fundamental to all we do at KCI," said Joe Woody, president & CEO, KCI, "As we close this corporate chapter and op ... Read more »

BUSINESS WIRE / ME NewsWire - OSAKA, Japan - Thursday, November 8th 2012 [ME NewsWire]

On the morning of November 14th, 2012, the North of Australia will witness a total solar eclipse. Panasonic, using its HIT(R) solar panels and lithium ion batteries for storage, will produce a live broadcast of this spectacular astronomical phenomenon via USTREAM.

Filming the Sun, Using the Sun. Join us in witnessing this incredible astronomical show! Enjoy the count down until the start of the broadcast on our Facebook and Twitter pages. Facebook：http://www.facebook.com/PanasonicEclipseLive http://facebook.com/PanasonicEclipseLiveBySolarPower Twitter：http://twitter.com/EclipsebySolar

Broadcasting from Two Bases The main camera at the seashore in Port Douglas and the sub camera at Fitzroy Island will shoot the total eclipse. Both cameras and broadcast systems will work on power generated by the solar panels and stored in the batteries. The videos will be available to view on the ... Read more »

FAIRFAX, Va. - Friday, November 9th 2012

    Fan names to be incorporated onto hood of Tony Stewart’s No. 14 Mobil 1/Office Depot Chevrolet at the Advocare 500k NASCAR Sprint Cup Series race at Phoenix International Raceway.
    The Vodafone McLaren Mercedes vehicles of Jenson Button and Lewis Hamilton will also feature fan names at 2012 United States Grand Prix in Austin, Texas.
    Fans won prize by achieving high scores on Mobil 1 Racing Academy online 3D racing game

(BUSINESS WIRE/ ME Newswire)-- ExxonMobil today announced that its Mobil 1 technology partners Stewart-Haas Racing and Vodafone McLaren Mercedes will feature the names of lucky fans on its race cars for one race as they prepare for the final stretch of the 2012 NASCAR and Formula 1™ calendars.

The No. 14 Mobil 1/Office Depot Chevrolet and Vodafone McLaren Mercedes MP4-27 will feature the names of 200 fansduring the Advocare 500k NASCAR Sprint Cup Se ... Read more »

Approximately 300,000 Team Members across 90 Countries and Territories to Volunteer in Communities

MCLEAN, Va. - Thursday, November 8th 2012 [ME NewsWire]

(BUSINESS WIRE)-- On November 11 – 18, Hilton Worldwide team members across 90 countries and territories will celebrate the company’s first Global Week of Service. This event will feature hundreds of projects around the globe and unite the company’s approximately 300,000 team members in more than 3,900 locations in their passion for hospitality and service by participating in hands-on volunteer projects and events in their local communities.

Hilton Worldwide’s Global Week of Service is a celebration of the company’s year-round commitment to volunteer service and is an expression of the company’s vision "to fill the earth with the light and warmth of hospitality,” building on founder Conrad N. Hilton’s legacy of service and responsibility to others. The company’s largest annual volunteer service event brings toget ... Read more »

INGELHEIM, Germany - Thursday, November 8th 2012 [ME NewsWire]

CAROLINA, a head-to-head cardiovascular outcome study comparing Trajenta® (linagliptin)with glimepiride completes recruitment

(BUSINESS WIRE)-- For Non-U.S. and Non-U.K. Media

Boehringer Ingelheim andEli Lilly and Company are pleased to announce that the recruitment of patients for CAROLINA (Cardiovascular Outcome Study of Linagliptin versus Glimepiride in Patients with Type 2 Diabetes)1 has been completed. Linagliptin is currently the only DPP-4 inhibitor that is being compared to an active comparator in a long-termprospective cardiovascular (CV) outcome study.

"CAROLINA has the potential to be a landmark study as it will evaluate cardiovascular safety of linagliptin compared to the sulphonylurea glimepiride. This is the first time a DPP-4 inhibitor is being directly compared to the sulphonylurea class in a long-term cardiovascular outcome study,” said Prof. Julio Rosenstock, Director of the ... Read more »